What ophthalmology is researching now
The topics gaining the most ground, ranked by the PubDaily Trend Score: new research, stronger evidence, new trials and new guidelines. 291 topics in 22 specialties, updated 18 Oct 2026.
Monthly reportThe fastest-rising topics in medicine: October 2026Read →Longer-acting anti-VEGF
Faricimab and high-dose aflibercept for retinal disease.
Myopia control in children
Atropine drops, defocus lenses and orthokeratology to slow myopia.
Key point: In myopic children, atropine efficacy increased nonlinearly with concentration and may plateau, while higher doses were associated with decreased accommodation and photophobia.
Ischaemic optic neuropathy
Non-arteritic anterior ischaemic optic neuropathy, including reports linked to GLP-1 drugs.
Key point: In acute NAION, increased early optic nerve head swelling rates were associated with visual field and visual acuity worsening by month 6.
AI in retinal imaging
Deep learning on fundus photos and OCT, including signs of systemic disease.
Diabetic retinopathy screening
Screening for diabetic retinopathy, including autonomous AI.
Gene therapy for inherited retinal disease
Gene therapy and optogenetics for inherited retinal dystrophies.
See all 12 ophthalmology topics
Every rising topic, with the papers behind it. Free for doctors.
How the Trend Score works
Four signals
Growth in new papers (35%), growth in randomised trials, meta-analyses and systematic reviews (25%), new clinical trials registered (20%), and new guidelines and consensus statements (20%), each over the last 12 months against the 12 before.
A score out of 100
Each signal is ranked against every topic we follow, so a score of 90 means the topic is ahead of about 90% of them. Rising fast: 80 and above. Rising: 55 to 79. Emerging: fewer than 100 papers the year before, too few to rank.
What it does not tell you
More research on a topic is not evidence that a treatment works. Open a topic to read the papers and guidelines themselves. Counts come from PubMed and ClinicalTrials.gov.